| PERIOD ENDING | 31-Aug-09 | 31-May-09 | 28-Feb-09 | 30-Nov-08 | | Total Revenue | 47,381 | 50,368 | 56,214 | 69,414 | | Cost of Revenue | 19,004 | 20,630 | 21,796 | 23,500 | | | Gross Profit | 28,377 | 29,738 | 34,418 | 45,914 | | | Operating Expenses | | Research Development | 7,940 | 9,180 | 9,216 | 10,096 | | Selling General and Administrative | 18,858 | 20,765 | 21,701 | 25,606 | | Non Recurring | (28) | 1,404 | 209 | 1,960 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,607 | (1,611) | 3,292 | 8,252 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (141) | 2,058 | (1,071) | (2,216) | | Earnings Before Interest And Taxes | 1,466 | 447 | 2,221 | 6,036 | | Interest Expense | 3,056 | 3,524 | 3,130 | 4,689 | | Income Before Tax | (1,590) | (3,077) | (909) | 1,347 | | Income Tax Expense | (2,119) | 1,048 | 627 | 138 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 529 | (4,125) | (1,536) | 1,209 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 529 | (4,125) | (1,536) | 1,209 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $529 | ($4,125) | ($1,536) | $1,209 |
|
0.51% Nasdaq 
Income Statement
